Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,293,011 papers from all fields of science
Search
Sign In
Create Free Account
cancer risk
Known as:
cancer risks
The probability that exposure to some agent or substance will adversely transform cells to replicate and form a malignant tumor. (EPA Terminology…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Broader (1)
Disease susceptibility
Li-Fraumeni Syndrome
Neoplasm, Residual
Residual Cancer
Residual Tumor
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
The peroxidase activity of mitochondrial superoxide dismutase.
Kristine Ansenberger-Fricano
,
D. Ganini
,
+6 authors
M. Bonini
Free Radical Biology & Medicine
2013
Corpus ID: 3952390
Highly Cited
2010
Highly Cited
2010
CYP 1A1 polymorphism and organochlorine pesticides levels in the etiology of prostate cancer.
Vivek Kumar
,
C. Yadav
,
+5 authors
B. Banerjee
Chemosphere
2010
Corpus ID: 30331114
Review
2005
Review
2005
Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death
E. Rakovitch
,
J. Pignol
,
+4 authors
M. Clemons
Breast Cancer Research and Treatment
2005
Corpus ID: 8757105
Purpose. Complementary and alternative medicines (CAMS) are frequently used by patients with breast cancer and their use may be…
Expand
Highly Cited
2005
Highly Cited
2005
Understanding the associations among education, employment characteristics, and smoking.
D. Wetter
,
Ludmila Cofta-Gunn
,
+6 authors
E. Gritz
Addictive Behaviours
2005
Corpus ID: 40722965
Highly Cited
2003
Highly Cited
2003
cis-9, trans-11 CLA derived endogenously from trans-11 18:1 reduces cancer risk in rats.
B. Corl
,
D. Barbano
,
D. Bauman
,
C. Ip
Journal of NutriLife
2003
Corpus ID: 4466127
The present study was designed to examine the effects of increasing dietary levels of vaccenic acid (VA) and cis-9, trans-11…
Expand
Review
2002
Review
2002
American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition.
R. Chlebowski
,
N. Col
,
+7 authors
D. Pfister
Journal of Clinical Oncology
2002
Corpus ID: 43015407
OBJECTIVE To update an evidence-based technology assessment of chemoprevention strategies for breast cancer risk reduction…
Expand
Highly Cited
2002
Highly Cited
2002
The study of tamoxifen and raloxifene: preliminary enrollment data from a randomized breast cancer risk reduction trial.
V. Vogel
,
J. Costantino
,
D. Wickerham
,
W. Cronin
,
N. Wolmark
Clinical Breast Cancer
2002
Corpus ID: 25686335
Tamoxifen reduced the risk of invasive breast cancer by 49% among women at increased risk for breast cancer in the Breast Cancer…
Expand
Highly Cited
2000
Highly Cited
2000
Effect of soy protein foods on low-density lipoprotein oxidation and ex vivo sex hormone receptor activity--a controlled crossover trial.
D. Jenkins
,
C. Kendall
,
+9 authors
E. Vidgen
Metabolism: Clinical and Experimental
2000
Corpus ID: 25185121
Highly Cited
2000
Highly Cited
2000
Update on cancer control in women
P. Boyle
,
P. Maisonneuve
,
P. Autier
International journal of gynaecology and…
2000
Corpus ID: 21567497
Highly Cited
1974
Highly Cited
1974
Estrogen receptors and the estrone hypothesis in relation to endometrial and breast cancer.
P. Siiteri
,
B. Schwarz
,
P. Macdonald
Gynecologic Oncology
1974
Corpus ID: 27218567
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE